BridgeBio Pharma, Inc. earnings per share and revenue

BBIO earnings per share for the last quarter are -0.39 USD whereas the estimation was -1.00 USD which accounts for 60.93% surprise. Company revenue for the same period amounts to 2.17 M USD despite the estimated figure of 3.96 M USD. Estimated earnings per share for the next quarter are -0.97 USD, and revenue is expected to reach 1.68 M USD. Also watch annual changes over time to get a bigger picture of BBIO earnings per share and revenue dynamics.